日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth

SMI-核糖体失活蛋白缀合物选择性抑制肿瘤细胞生长

Roy, Saumya; Axup, Jun Y; Forsyth, Jane S; Goswami, Rajib K; Hutchins, Benjamin M; Bajuri, Krishna M; Kazane, Stephanie A; Smider, Vaughn V; Felding, Brunhilde H; Sinha, Subhash C

A CXCR4-targeted site-specific antibody-drug conjugate

CXCR4靶向位点特异性抗体-药物偶联物

Kularatne, Sumith A; Deshmukh, Vishal; Ma, Jennifer; Tardif, Virginie; Lim, Reyna K V; Pugh, Holly M; Sun, Ying; Manibusan, Anthony; Sellers, Aaron J; Barnett, Richard S; Srinagesh, Shailaja; Forsyth, Jane S; Hassenpflug, Wolf; Tian, Feng; Javahishvili, Tsotne; Felding-Habermann, Brunhilde; Lawson, Brian R; Kazane, Stephanie A; Schultz, Peter G

Selective formation of covalent protein heterodimers with an unnatural amino acid

选择性地与非天然氨基酸形成共价蛋白质异二聚体

Hutchins, Benjamin M; Kazane, Stephanie A; Staflin, Karin; Forsyth, Jane S; Felding-Habermann, Brunhilde; Smider, Vaughn V; Schultz, Peter G

Targeting activated integrin alphavbeta3 with patient-derived antibodies impacts late-stage multiorgan metastasis.

利用患者来源的抗体靶向活化的整合素αvβ3,可影响晚期多器官转移

Staflin Karin, Krueger Joseph S, Hachmann Janna, Forsyth Jane S, Lorger Mihaela, Steiniger Sebastian C J, Mee Jenny, Pop Cristina, Salvesen Guy S, Janda Kim D, Felding-Habermann Brunhilde

Multiple catalytic aldolase antibodies suitable for chemical programming

多种适用于化学编程的催化醛缩酶抗体

Goswami, Rajib Kumar; Huang, Zheng-Zheng; Forsyth, Jane S; Felding-Habermann, Brunhilde; Sinha, Subhash C